Adherence to Antiretroviral Therapy and Its Association with Sexual Behavior in a National Sample of Women with Human Immunodeficiency Virus
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Author
Wilson, Tracey E.Barrón, Yolanda
Cohen, Mardge
Richardson, Jean
Greenblatt, Ruth
Sacks, Henry S.
Young, Mary
Journal title
Clinical Infectious DiseasesDate Published
2002-01-09Publication Volume
34Publication Issue
4Publication Begin page
529Publication End page
534
Metadata
Show full item recordAbstract
To delineate the relationship between adherence to human immunodeficiency virus (HIV) therapy and sexual behavior among HIV type 1-infected women in the United States, data were collected from October 1998 through March 1999 from 766 HIV-positive women on adherence to therapy, risk behavior, and disease markers. Adherence rates of >/=95% were reported by 66% of the patients. In multivariate analyses, patients with lower rates of adherence tended to be younger (odds ratio [OR], 1.69), to be active drug users (OR, 2.27), to have detectable virus load levels (OR, 2.00), and to have a lower quality of life (OR, 1.20). Among sexually active women, lower adherence rates were associated with an increased risk for inconsistent condom use (adjusted OR, 2.17). Although counseling regarding sexual behavior and adherence to treatment regimens are often addressed separately, our data highlight the importance of discussing these factors in relation to one another, particularly with regard to patients experiencing virologic failure.Citation
Wilson TE, Barrón Y, Cohen M, Richardson J, Greenblatt R, Sacks HS, Young M; Women's Interagency HIV Study. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis. 2002 Feb 15;34(4):529-34. doi: 10.1086/338397. Epub 2002 Jan 9. PMID: 11797182.DOI
10.1086/338397ae974a485f413a2113503eed53cd6c53
10.1086/338397
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
Related articles
- Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
- Authors: Van Vaerenbergh K
- Issue date: 2001
- Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.
- Authors: Murphy DA, Belzer M, Durako SJ, Sarr M, Wilson CM, Muenz LR, Adolescent Medicine HIV/AIDS Research Network
- Issue date: 2005 Aug
- Analysis of the influence of therapy and viral suppression on high-risk sexual behaviour and sexually transmitted infections among patients infected with human immunodeficiency virus in Taiwan.
- Authors: Chen SC, Wang ST, Chen KT, Yan TR, Tang LH, Lin CC, Yen SF
- Issue date: 2006 Jul
- Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users.
- Authors: Tun W, Gange SJ, Vlahov D, Strathdee SA, Celentano DD
- Issue date: 2004 Apr 15
- Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors.
- Authors: Maggiolo F, Ravasio L, Ripamonti D, Gregis G, Quinzan G, Arici C, Airoldi M, Suter F
- Issue date: 2005 Jan 1